Review





Similar Products

microscan walkaway 40 system  (Siemens Healthineers)
86
Siemens Healthineers microscan walkaway 40 system
Microscan Walkaway 40 System, supplied by Siemens Healthineers, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/microscan walkaway 40 system/product/Siemens Healthineers
Average 86 stars, based on 1 article reviews
microscan walkaway 40 system - by Bioz Stars, 2026-05
86/100 stars
  Buy from Supplier
microscan autoscan 4 system  (Dade Behring)
86
Dade Behring microscan autoscan 4 system
Microscan Autoscan 4 System, supplied by Dade Behring, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/microscan autoscan 4 system/product/Dade Behring
Average 86 stars, based on 1 article reviews
microscan autoscan 4 system - by Bioz Stars, 2026-05
86/100 stars
  Buy from Supplier
mhz microscan transducer  (FUJIFILM VisualSonics Inc)
86
FUJIFILM VisualSonics Inc mhz microscan transducer
Mhz Microscan Transducer, supplied by FUJIFILM VisualSonics Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/mhz microscan transducer/product/FUJIFILM VisualSonics Inc
Average 86 stars, based on 1 article reviews
mhz microscan transducer - by Bioz Stars, 2026-05
86/100 stars
  Buy from Supplier
microscan walkway 96 system  (Siemens Healthineers)
86
Siemens Healthineers microscan walkway 96 system
Microscan Walkway 96 System, supplied by Siemens Healthineers, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/microscan walkway 96 system/product/Siemens Healthineers
Average 86 stars, based on 1 article reviews
microscan walkway 96 system - by Bioz Stars, 2026-05
86/100 stars
  Buy from Supplier
microscan walkaway 96 plus automated microbial susceptibility system  (Siemens Healthineers)
86
Siemens Healthineers microscan walkaway 96 plus automated microbial susceptibility system
Microscan Walkaway 96 Plus Automated Microbial Susceptibility System, supplied by Siemens Healthineers, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/microscan walkaway 96 plus automated microbial susceptibility system/product/Siemens Healthineers
Average 86 stars, based on 1 article reviews
microscan walkaway 96 plus automated microbial susceptibility system - by Bioz Stars, 2026-05
86/100 stars
  Buy from Supplier
mhz microscan linear ultrasound imaging array  (FUJIFILM VisualSonics Inc)
86
FUJIFILM VisualSonics Inc mhz microscan linear ultrasound imaging array
(A) CAD rendering of custom <t>ultrasound-guided</t> FUS system consisting of a 4-element 3.78 MHz transducer axially co-registered with 15 MHz <t>MicroScan</t> linear ultrasound imaging array. (B) Representative partial ablation scheme and (C) B-mode ultrasound images of E0771 tumor either before/during (top) or after (bottom) T-FUS treatment, with hyperechoic signature present after treatment (arrow). (D) Custom grading scale of presence of hyperechoic signal post-T-FUS treatment across all murine breast cancer models. (E) Overview of experimental timeline. (F) Representative H&E staining, along with cleaved caspase 3, PARP, and HSP70 staining, was performed on control and T-FUS-treated E0771 tumors 24 hours post-treatment. (G) In vivo surrogate measurements of ATP levels via bioluminescence at 10 minutes after T-FUS. (H) Temporal radiance curve (proxying relative ATP levels) for a sham vs. tumor volume-matched T-FUS mice (E0771 model). Significance assessed by Wilcoxon rank-sum test. **p=0.0028. H-L) (I) Percentage of B cells (CD19 + , MHCII + ), (J) macrophages (MФs; F480 + , Ly6C - ), (K) cDCs (CD11c + , MHCII + ), (L) monocytes (F480 + , Ly6C + ), and (M) granulocytes (CD11b + , Ly6G + ) out of CD45+ cells in the tumor. Significance assessed by Welch’s T-test.*p < 0.05, **p < 0.01, and ***p < 0.001 vs. control, respectively.
Mhz Microscan Linear Ultrasound Imaging Array, supplied by FUJIFILM VisualSonics Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/mhz microscan linear ultrasound imaging array/product/FUJIFILM VisualSonics Inc
Average 86 stars, based on 1 article reviews
mhz microscan linear ultrasound imaging array - by Bioz Stars, 2026-05
86/100 stars
  Buy from Supplier
microscan walkaway 96 plus system  (Siemens Healthineers)
86
Siemens Healthineers microscan walkaway 96 plus system
(A) CAD rendering of custom <t>ultrasound-guided</t> FUS system consisting of a 4-element 3.78 MHz transducer axially co-registered with 15 MHz <t>MicroScan</t> linear ultrasound imaging array. (B) Representative partial ablation scheme and (C) B-mode ultrasound images of E0771 tumor either before/during (top) or after (bottom) T-FUS treatment, with hyperechoic signature present after treatment (arrow). (D) Custom grading scale of presence of hyperechoic signal post-T-FUS treatment across all murine breast cancer models. (E) Overview of experimental timeline. (F) Representative H&E staining, along with cleaved caspase 3, PARP, and HSP70 staining, was performed on control and T-FUS-treated E0771 tumors 24 hours post-treatment. (G) In vivo surrogate measurements of ATP levels via bioluminescence at 10 minutes after T-FUS. (H) Temporal radiance curve (proxying relative ATP levels) for a sham vs. tumor volume-matched T-FUS mice (E0771 model). Significance assessed by Wilcoxon rank-sum test. **p=0.0028. H-L) (I) Percentage of B cells (CD19 + , MHCII + ), (J) macrophages (MФs; F480 + , Ly6C - ), (K) cDCs (CD11c + , MHCII + ), (L) monocytes (F480 + , Ly6C + ), and (M) granulocytes (CD11b + , Ly6G + ) out of CD45+ cells in the tumor. Significance assessed by Welch’s T-test.*p < 0.05, **p < 0.01, and ***p < 0.001 vs. control, respectively.
Microscan Walkaway 96 Plus System, supplied by Siemens Healthineers, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/microscan walkaway 96 plus system/product/Siemens Healthineers
Average 86 stars, based on 1 article reviews
microscan walkaway 96 plus system - by Bioz Stars, 2026-05
86/100 stars
  Buy from Supplier
microscan system  (Dade Behring)
86
Dade Behring microscan system
(A) CAD rendering of custom <t>ultrasound-guided</t> FUS system consisting of a 4-element 3.78 MHz transducer axially co-registered with 15 MHz <t>MicroScan</t> linear ultrasound imaging array. (B) Representative partial ablation scheme and (C) B-mode ultrasound images of E0771 tumor either before/during (top) or after (bottom) T-FUS treatment, with hyperechoic signature present after treatment (arrow). (D) Custom grading scale of presence of hyperechoic signal post-T-FUS treatment across all murine breast cancer models. (E) Overview of experimental timeline. (F) Representative H&E staining, along with cleaved caspase 3, PARP, and HSP70 staining, was performed on control and T-FUS-treated E0771 tumors 24 hours post-treatment. (G) In vivo surrogate measurements of ATP levels via bioluminescence at 10 minutes after T-FUS. (H) Temporal radiance curve (proxying relative ATP levels) for a sham vs. tumor volume-matched T-FUS mice (E0771 model). Significance assessed by Wilcoxon rank-sum test. **p=0.0028. H-L) (I) Percentage of B cells (CD19 + , MHCII + ), (J) macrophages (MФs; F480 + , Ly6C - ), (K) cDCs (CD11c + , MHCII + ), (L) monocytes (F480 + , Ly6C + ), and (M) granulocytes (CD11b + , Ly6G + ) out of CD45+ cells in the tumor. Significance assessed by Welch’s T-test.*p < 0.05, **p < 0.01, and ***p < 0.001 vs. control, respectively.
Microscan System, supplied by Dade Behring, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/microscan system/product/Dade Behring
Average 86 stars, based on 1 article reviews
microscan system - by Bioz Stars, 2026-05
86/100 stars
  Buy from Supplier

Image Search Results


(A) CAD rendering of custom ultrasound-guided FUS system consisting of a 4-element 3.78 MHz transducer axially co-registered with 15 MHz MicroScan linear ultrasound imaging array. (B) Representative partial ablation scheme and (C) B-mode ultrasound images of E0771 tumor either before/during (top) or after (bottom) T-FUS treatment, with hyperechoic signature present after treatment (arrow). (D) Custom grading scale of presence of hyperechoic signal post-T-FUS treatment across all murine breast cancer models. (E) Overview of experimental timeline. (F) Representative H&E staining, along with cleaved caspase 3, PARP, and HSP70 staining, was performed on control and T-FUS-treated E0771 tumors 24 hours post-treatment. (G) In vivo surrogate measurements of ATP levels via bioluminescence at 10 minutes after T-FUS. (H) Temporal radiance curve (proxying relative ATP levels) for a sham vs. tumor volume-matched T-FUS mice (E0771 model). Significance assessed by Wilcoxon rank-sum test. **p=0.0028. H-L) (I) Percentage of B cells (CD19 + , MHCII + ), (J) macrophages (MФs; F480 + , Ly6C - ), (K) cDCs (CD11c + , MHCII + ), (L) monocytes (F480 + , Ly6C + ), and (M) granulocytes (CD11b + , Ly6G + ) out of CD45+ cells in the tumor. Significance assessed by Welch’s T-test.*p < 0.05, **p < 0.01, and ***p < 0.001 vs. control, respectively.

Journal: bioRxiv

Article Title: Focused Ultrasound Thermal Ablation and CD40 Agonism Reprograms Breast Tumor Immunity to Drive Regression and Memory

doi: 10.64898/2026.03.02.708396

Figure Lengend Snippet: (A) CAD rendering of custom ultrasound-guided FUS system consisting of a 4-element 3.78 MHz transducer axially co-registered with 15 MHz MicroScan linear ultrasound imaging array. (B) Representative partial ablation scheme and (C) B-mode ultrasound images of E0771 tumor either before/during (top) or after (bottom) T-FUS treatment, with hyperechoic signature present after treatment (arrow). (D) Custom grading scale of presence of hyperechoic signal post-T-FUS treatment across all murine breast cancer models. (E) Overview of experimental timeline. (F) Representative H&E staining, along with cleaved caspase 3, PARP, and HSP70 staining, was performed on control and T-FUS-treated E0771 tumors 24 hours post-treatment. (G) In vivo surrogate measurements of ATP levels via bioluminescence at 10 minutes after T-FUS. (H) Temporal radiance curve (proxying relative ATP levels) for a sham vs. tumor volume-matched T-FUS mice (E0771 model). Significance assessed by Wilcoxon rank-sum test. **p=0.0028. H-L) (I) Percentage of B cells (CD19 + , MHCII + ), (J) macrophages (MФs; F480 + , Ly6C - ), (K) cDCs (CD11c + , MHCII + ), (L) monocytes (F480 + , Ly6C + ), and (M) granulocytes (CD11b + , Ly6G + ) out of CD45+ cells in the tumor. Significance assessed by Welch’s T-test.*p < 0.05, **p < 0.01, and ***p < 0.001 vs. control, respectively.

Article Snippet: The system was powered by a 200W amplifier (Electronics & Innovation 1020L) driven by an arbitrary function generator (Tektronix AFG3022C), and axially co-registered to a 15 MHz MicroScan linear ultrasound imaging array (MS200; VisualSonics).

Techniques: Imaging, Staining, Control, In Vivo